Lawrence Otto Klein, CBO & COO at CRISPR Therapeutics AG (CRSP), sold 41,798 shares at $211.44 ($9.0M) on 2021-01-15, disclosed to the SEC on 2021-01-20.
Open-market sale of $9.0M CRSP by CBO & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $211.44 | 2,911 | $616K | 6.8% |
| 2 | $211.44 | 2,911 | $616K | 6.8% |
| 3 | $212.20 | 634 | $135K | 1.5% |
| 4 | $212.20 | 634 | $135K | 1.5% |
| 5 | $212.54 | 2,555 | $543K | 6.0% |
| 6 | $212.54 | 2,555 |
| $543K |
| 6.0% |
| 7 | $213.64 | 2,800 | $598K | 6.6% |
| 8 | $213.71 | 1,200 | $256K | 2.8% |
| 9 | $214.46 | 1,400 | $300K | 3.3% |
| 10 | $214.60 | 700 | $150K | 1.7% |
| 11 | $216.24 | 400 | $86K | 1.0% |
| 12 | $216.39 | 1,500 | $325K | 3.6% |
| 13 | $217.42 | 9,997 | $2.2M | 24.2% |
| 14 | $217.42 | 9,997 | $2.2M | 24.2% |
| 15 | $217.45 | 200 | $43K | 0.5% |
| 16 | $218.54 | 701 | $153K | 1.7% |
| 17 | $218.54 | 701 | $153K | 1.7% |
| 18 | $219.99 | 2 | $440 | 0.0% |
| Total | $215.32 avg | 41,798 | $9.0M | 100% |
| Filing → |
| ORKA | SELL | 2026-09-01 | $6.9M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |